nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer
|
Han, Ji-Youn |
|
2013 |
79 |
2 |
p. 137-142 6 p. |
artikel |
2 |
Clinical and molecular features in patients with advanced non-small-cell lung carcinoma refractory to first-line platinum-based chemotherapy
|
Giroux Leprieur, E. |
|
2013 |
79 |
2 |
p. 167-172 6 p. |
artikel |
3 |
Clinical prognostic factors and grading system for rib fracture following stereotactic body radiation therapy (SBRT) in patients with peripheral lung tumors
|
Kim, Su Ssan |
|
2013 |
79 |
2 |
p. 161-166 6 p. |
artikel |
4 |
Contents
|
|
|
2013 |
79 |
2 |
p. v-vi nvt p. |
artikel |
5 |
Dietary restriction suppresses tumor growth, reduces angiogenesis, and improves tumor microenvironment in human non-small-cell lung cancer xenografts
|
Lin, Bao-Quan |
|
2013 |
79 |
2 |
p. 111-117 7 p. |
artikel |
6 |
Distinctive histopathological features of lepidic growth predominant node-negative adenocarcinomas 3–5cm in size
|
Takahashi, Yusuke |
|
2013 |
79 |
2 |
p. 118-124 7 p. |
artikel |
7 |
Editorial Board
|
|
|
2013 |
79 |
2 |
p. iii- 1 p. |
artikel |
8 |
18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients
|
Roca, Elisa |
|
2013 |
79 |
2 |
p. 187-190 4 p. |
artikel |
9 |
FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients
|
Wang, Yu |
|
2013 |
79 |
2 |
p. 173-179 7 p. |
artikel |
10 |
Preoperative serum CYFRA 21-1 level as a prognostic factor in surgically treated adenocarcinoma of lung
|
Park, Seong Yong |
|
2013 |
79 |
2 |
p. 156-160 5 p. |
artikel |
11 |
Second-line pemetrexed versus docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer: A randomized, open-label study
|
Sun, Y. |
|
2013 |
79 |
2 |
p. 143-150 8 p. |
artikel |
12 |
Suppression of non-small cell lung cancer proliferation and tumorigenicity by DENND2D
|
Ling, Bing |
|
2013 |
79 |
2 |
p. 104-110 7 p. |
artikel |
13 |
Survivin expression impacts prognostically on NSCLC but not SCLC
|
Rosato, Antonio |
|
2013 |
79 |
2 |
p. 180-186 7 p. |
artikel |
14 |
The impact on the multidisciplinary team of molecular profiling for personalized therapy in non-small cell lung cancer
|
Blackhall, Fiona |
|
2013 |
79 |
2 |
p. 101-103 3 p. |
artikel |
15 |
The pathological confirmation rate of lung cancer in England using the NLCA database
|
Khakwani, Aamir |
|
2013 |
79 |
2 |
p. 125-131 7 p. |
artikel |
16 |
The T393C polymorphism of GNAS1 is a predictor for relapse and survival in resectable non-small cell lung cancer
|
Uzunoglu, Faik Güntac |
|
2013 |
79 |
2 |
p. 151-155 5 p. |
artikel |
17 |
Usp22 and its evolving role in systemic carcinogenesis
|
Kapoor, Shailendra |
|
2013 |
79 |
2 |
p. 191- 1 p. |
artikel |
18 |
What causes false-negative PET findings for solid-type lung cancer?
|
Iwano, Shingo |
|
2013 |
79 |
2 |
p. 132-136 5 p. |
artikel |